Acute myeloid leukemia?(AML) is a type of blood cancer. Learn more about AML causes, symptoms, diagnosis, and treatment.
This report aims to provide a comprehensive presentation of the global market for Acute Myeloid Leukemia, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acute Myeloid Leukemia. This report contains market size and forecasts of Acute Myeloid Leukemia in global, including the following market information:
Global Acute Myeloid Leukemia Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Acute Myeloid Leukemia market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Chemotherapy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Acute Myeloid Leukemia include GSK, Novartis, Roche, Bristol-Myers Squibb, Celgene, Clavis Pharma ASA, Daiichi Sankyo, Eisai and Teva, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Acute Myeloid Leukemia companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Acute Myeloid Leukemia Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Acute Myeloid Leukemia Market Segment Percentages, by Type, 2022 (%)
Chemotherapy
Targeted Therapy
Global Acute Myeloid Leukemia Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Acute Myeloid Leukemia Market Segment Percentages, by Application, 2022 (%)
Adults
Children
Global Acute Myeloid Leukemia Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Acute Myeloid Leukemia Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Acute Myeloid Leukemia revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Acute Myeloid Leukemia revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GSK
Novartis
Roche
Bristol-Myers Squibb
Celgene
Clavis Pharma ASA
Daiichi Sankyo
Eisai
Teva
Sunesis Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Acute Myeloid Leukemia, market overview.
Chapter 2: Global Acute Myeloid Leukemia market size in revenue.
Chapter 3: Detailed analysis of Acute Myeloid Leukemia company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Acute Myeloid Leukemia in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Acute Myeloid Leukemia Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Acute Myeloid Leukemia Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Acute Myeloid Leukemia Overall Market Size
2.1 Global Acute Myeloid Leukemia Market Size: 2022 VS 2030
2.2 Global Acute Myeloid Leukemia Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Acute Myeloid Leukemia Players in Global Market
3.2 Top Global Acute Myeloid Leukemia Companies Ranked by Revenue
3.3 Global Acute Myeloid Leukemia Revenue by Companies
3.4 Top 3 and Top 5 Acute Myeloid Leukemia Companies in Global Market, by Revenue in 2022
3.5 Global Companies Acute Myeloid Leukemia Product Type
3.6 Tier 1, Tier 2 and Tier 3 Acute Myeloid Leukemia Players in Global Market
3.6.1 List of Global Tier 1 Acute Myeloid Leukemia Companies
3.6.2 List of Global Tier 2 and Tier 3 Acute Myeloid Leukemia Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Acute Myeloid Leukemia Market Size Markets, 2022 & 2030
4.1.2 Chemotherapy
4.1.3 Targeted Therapy
4.2 By Type - Global Acute Myeloid Leukemia Revenue & Forecasts
4.2.1 By Type - Global Acute Myeloid Leukemia Revenue, 2018-2023
4.2.2 By Type - Global Acute Myeloid Leukemia Revenue, 2024-2030
4.2.3 By Type - Global Acute Myeloid Leukemia Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Acute Myeloid Leukemia Market Size, 2022 & 2030
5.1.2 Adults
5.1.3 Children
5.2 By Application - Global Acute Myeloid Leukemia Revenue & Forecasts
5.2.1 By Application - Global Acute Myeloid Leukemia Revenue, 2018-2023
5.2.2 By Application - Global Acute Myeloid Leukemia Revenue, 2024-2030
5.2.3 By Application - Global Acute Myeloid Leukemia Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Acute Myeloid Leukemia Market Size, 2022 & 2030
6.2 By Region - Global Acute Myeloid Leukemia Revenue & Forecasts
6.2.1 By Region - Global Acute Myeloid Leukemia Revenue, 2018-2023
6.2.2 By Region - Global Acute Myeloid Leukemia Revenue, 2024-2030
6.2.3 By Region - Global Acute Myeloid Leukemia Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Acute Myeloid Leukemia Revenue, 2018-2030
6.3.2 US Acute Myeloid Leukemia Market Size, 2018-2030
6.3.3 Canada Acute Myeloid Leukemia Market Size, 2018-2030
6.3.4 Mexico Acute Myeloid Leukemia Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Acute Myeloid Leukemia Revenue, 2018-2030
6.4.2 Germany Acute Myeloid Leukemia Market Size, 2018-2030
6.4.3 France Acute Myeloid Leukemia Market Size, 2018-2030
6.4.4 U.K. Acute Myeloid Leukemia Market Size, 2018-2030
6.4.5 Italy Acute Myeloid Leukemia Market Size, 2018-2030
6.4.6 Russia Acute Myeloid Leukemia Market Size, 2018-2030
6.4.7 Nordic Countries Acute Myeloid Leukemia Market Size, 2018-2030
6.4.8 Benelux Acute Myeloid Leukemia Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Acute Myeloid Leukemia Revenue, 2018-2030
6.5.2 China Acute Myeloid Leukemia Market Size, 2018-2030
6.5.3 Japan Acute Myeloid Leukemia Market Size, 2018-2030
6.5.4 South Korea Acute Myeloid Leukemia Market Size, 2018-2030
6.5.5 Southeast Asia Acute Myeloid Leukemia Market Size, 2018-2030
6.5.6 India Acute Myeloid Leukemia Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Acute Myeloid Leukemia Revenue, 2018-2030
6.6.2 Brazil Acute Myeloid Leukemia Market Size, 2018-2030
6.6.3 Argentina Acute Myeloid Leukemia Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Acute Myeloid Leukemia Revenue, 2018-2030
6.7.2 Turkey Acute Myeloid Leukemia Market Size, 2018-2030
6.7.3 Israel Acute Myeloid Leukemia Market Size, 2018-2030
6.7.4 Saudi Arabia Acute Myeloid Leukemia Market Size, 2018-2030
6.7.5 UAE Acute Myeloid Leukemia Market Size, 2018-2030
7 Acute Myeloid Leukemia Companies Profiles
7.1 GSK
7.1.1 GSK Company Summary
7.1.2 GSK Business Overview
7.1.3 GSK Acute Myeloid Leukemia Major Product Offerings
7.1.4 GSK Acute Myeloid Leukemia Revenue in Global Market (2018-2023)
7.1.5 GSK Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Acute Myeloid Leukemia Major Product Offerings
7.2.4 Novartis Acute Myeloid Leukemia Revenue in Global Market (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 Roche
7.3.1 Roche Company Summary
7.3.2 Roche Business Overview
7.3.3 Roche Acute Myeloid Leukemia Major Product Offerings
7.3.4 Roche Acute Myeloid Leukemia Revenue in Global Market (2018-2023)
7.3.5 Roche Key News & Latest Developments
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Company Summary
7.4.2 Bristol-Myers Squibb Business Overview
7.4.3 Bristol-Myers Squibb Acute Myeloid Leukemia Major Product Offerings
7.4.4 Bristol-Myers Squibb Acute Myeloid Leukemia Revenue in Global Market (2018-2023)
7.4.5 Bristol-Myers Squibb Key News & Latest Developments
7.5 Celgene
7.5.1 Celgene Company Summary
7.5.2 Celgene Business Overview
7.5.3 Celgene Acute Myeloid Leukemia Major Product Offerings
7.5.4 Celgene Acute Myeloid Leukemia Revenue in Global Market (2018-2023)
7.5.5 Celgene Key News & Latest Developments
7.6 Clavis Pharma ASA
7.6.1 Clavis Pharma ASA Company Summary
7.6.2 Clavis Pharma ASA Business Overview
7.6.3 Clavis Pharma ASA Acute Myeloid Leukemia Major Product Offerings
7.6.4 Clavis Pharma ASA Acute Myeloid Leukemia Revenue in Global Market (2018-2023)
7.6.5 Clavis Pharma ASA Key News & Latest Developments
7.7 Daiichi Sankyo
7.7.1 Daiichi Sankyo Company Summary
7.7.2 Daiichi Sankyo Business Overview
7.7.3 Daiichi Sankyo Acute Myeloid Leukemia Major Product Offerings
7.7.4 Daiichi Sankyo Acute Myeloid Leukemia Revenue in Global Market (2018-2023)
7.7.5 Daiichi Sankyo Key News & Latest Developments
7.8 Eisai
7.8.1 Eisai Company Summary
7.8.2 Eisai Business Overview
7.8.3 Eisai Acute Myeloid Leukemia Major Product Offerings
7.8.4 Eisai Acute Myeloid Leukemia Revenue in Global Market (2018-2023)
7.8.5 Eisai Key News & Latest Developments
7.9 Teva
7.9.1 Teva Company Summary
7.9.2 Teva Business Overview
7.9.3 Teva Acute Myeloid Leukemia Major Product Offerings
7.9.4 Teva Acute Myeloid Leukemia Revenue in Global Market (2018-2023)
7.9.5 Teva Key News & Latest Developments
7.10 Sunesis Pharmaceuticals
7.10.1 Sunesis Pharmaceuticals Company Summary
7.10.2 Sunesis Pharmaceuticals Business Overview
7.10.3 Sunesis Pharmaceuticals Acute Myeloid Leukemia Major Product Offerings
7.10.4 Sunesis Pharmaceuticals Acute Myeloid Leukemia Revenue in Global Market (2018-2023)
7.10.5 Sunesis Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Acute Myeloid Leukemia Market Opportunities & Trends in Global Market
Table 2. Acute Myeloid Leukemia Market Drivers in Global Market
Table 3. Acute Myeloid Leukemia Market Restraints in Global Market
Table 4. Key Players of Acute Myeloid Leukemia in Global Market
Table 5. Top Acute Myeloid Leukemia Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Acute Myeloid Leukemia Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Acute Myeloid Leukemia Revenue Share by Companies, 2018-2023
Table 8. Global Companies Acute Myeloid Leukemia Product Type
Table 9. List of Global Tier 1 Acute Myeloid Leukemia Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Acute Myeloid Leukemia Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Acute Myeloid Leukemia Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Acute Myeloid Leukemia Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Acute Myeloid Leukemia Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Acute Myeloid Leukemia Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Acute Myeloid Leukemia Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Acute Myeloid Leukemia Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Acute Myeloid Leukemia Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Acute Myeloid Leukemia Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Acute Myeloid Leukemia Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Acute Myeloid Leukemia Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Acute Myeloid Leukemia Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Acute Myeloid Leukemia Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Acute Myeloid Leukemia Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Acute Myeloid Leukemia Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Acute Myeloid Leukemia Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Acute Myeloid Leukemia Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Acute Myeloid Leukemia Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Acute Myeloid Leukemia Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Acute Myeloid Leukemia Revenue, (US$, Mn), 2024-2030
Table 30. GSK Company Summary
Table 31. GSK Acute Myeloid Leukemia Product Offerings
Table 32. GSK Acute Myeloid Leukemia Revenue (US$, Mn) & (2018-2023)
Table 33. GSK Key News & Latest Developments
Table 34. Novartis Company Summary
Table 35. Novartis Acute Myeloid Leukemia Product Offerings
Table 36. Novartis Acute Myeloid Leukemia Revenue (US$, Mn) & (2018-2023)
Table 37. Novartis Key News & Latest Developments
Table 38. Roche Company Summary
Table 39. Roche Acute Myeloid Leukemia Product Offerings
Table 40. Roche Acute Myeloid Leukemia Revenue (US$, Mn) & (2018-2023)
Table 41. Roche Key News & Latest Developments
Table 42. Bristol-Myers Squibb Company Summary
Table 43. Bristol-Myers Squibb Acute Myeloid Leukemia Product Offerings
Table 44. Bristol-Myers Squibb Acute Myeloid Leukemia Revenue (US$, Mn) & (2018-2023)
Table 45. Bristol-Myers Squibb Key News & Latest Developments
Table 46. Celgene Company Summary
Table 47. Celgene Acute Myeloid Leukemia Product Offerings
Table 48. Celgene Acute Myeloid Leukemia Revenue (US$, Mn) & (2018-2023)
Table 49. Celgene Key News & Latest Developments
Table 50. Clavis Pharma ASA Company Summary
Table 51. Clavis Pharma ASA Acute Myeloid Leukemia Product Offerings
Table 52. Clavis Pharma ASA Acute Myeloid Leukemia Revenue (US$, Mn) & (2018-2023)
Table 53. Clavis Pharma ASA Key News & Latest Developments
Table 54. Daiichi Sankyo Company Summary
Table 55. Daiichi Sankyo Acute Myeloid Leukemia Product Offerings
Table 56. Daiichi Sankyo Acute Myeloid Leukemia Revenue (US$, Mn) & (2018-2023)
Table 57. Daiichi Sankyo Key News & Latest Developments
Table 58. Eisai Company Summary
Table 59. Eisai Acute Myeloid Leukemia Product Offerings
Table 60. Eisai Acute Myeloid Leukemia Revenue (US$, Mn) & (2018-2023)
Table 61. Eisai Key News & Latest Developments
Table 62. Teva Company Summary
Table 63. Teva Acute Myeloid Leukemia Product Offerings
Table 64. Teva Acute Myeloid Leukemia Revenue (US$, Mn) & (2018-2023)
Table 65. Teva Key News & Latest Developments
Table 66. Sunesis Pharmaceuticals Company Summary
Table 67. Sunesis Pharmaceuticals Acute Myeloid Leukemia Product Offerings
Table 68. Sunesis Pharmaceuticals Acute Myeloid Leukemia Revenue (US$, Mn) & (2018-2023)
Table 69. Sunesis Pharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Acute Myeloid Leukemia Segment by Type in 2022
Figure 2. Acute Myeloid Leukemia Segment by Application in 2022
Figure 3. Global Acute Myeloid Leukemia Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Acute Myeloid Leukemia Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Acute Myeloid Leukemia Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Acute Myeloid Leukemia Revenue in 2022
Figure 8. By Type - Global Acute Myeloid Leukemia Revenue Market Share, 2018-2030
Figure 9. By Application - Global Acute Myeloid Leukemia Revenue Market Share, 2018-2030
Figure 10. By Type - Global Acute Myeloid Leukemia Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Acute Myeloid Leukemia Revenue Market Share, 2018-2030
Figure 12. By Application - Global Acute Myeloid Leukemia Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Acute Myeloid Leukemia Revenue Market Share, 2018-2030
Figure 14. By Region - Global Acute Myeloid Leukemia Revenue Market Share, 2018-2030
Figure 15. By Country - North America Acute Myeloid Leukemia Revenue Market Share, 2018-2030
Figure 16. US Acute Myeloid Leukemia Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Acute Myeloid Leukemia Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Acute Myeloid Leukemia Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Acute Myeloid Leukemia Revenue Market Share, 2018-2030
Figure 20. Germany Acute Myeloid Leukemia Revenue, (US$, Mn), 2018-2030
Figure 21. France Acute Myeloid Leukemia Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Acute Myeloid Leukemia Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Acute Myeloid Leukemia Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Acute Myeloid Leukemia Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Acute Myeloid Leukemia Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Acute Myeloid Leukemia Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Acute Myeloid Leukemia Revenue Market Share, 2018-2030
Figure 28. China Acute Myeloid Leukemia Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Acute Myeloid Leukemia Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Acute Myeloid Leukemia Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Acute Myeloid Leukemia Revenue, (US$, Mn), 2018-2030
Figure 32. India Acute Myeloid Leukemia Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Acute Myeloid Leukemia Revenue Market Share, 2018-2030
Figure 34. Brazil Acute Myeloid Leukemia Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Acute Myeloid Leukemia Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Acute Myeloid Leukemia Revenue Market Share, 2018-2030
Figure 37. Turkey Acute Myeloid Leukemia Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Acute Myeloid Leukemia Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Acute Myeloid Leukemia Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Acute Myeloid Leukemia Revenue, (US$, Mn), 2018-2030
Figure 41. GSK Acute Myeloid Leukemia Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Novartis Acute Myeloid Leukemia Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Roche Acute Myeloid Leukemia Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Bristol-Myers Squibb Acute Myeloid Leukemia Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Celgene Acute Myeloid Leukemia Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Clavis Pharma ASA Acute Myeloid Leukemia Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Daiichi Sankyo Acute Myeloid Leukemia Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Eisai Acute Myeloid Leukemia Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Teva Acute Myeloid Leukemia Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Sunesis Pharmaceuticals Acute Myeloid Leukemia Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
